Medical Weight Loss for Sanford, Florida Residents

Sanford, Florida residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Sanford through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Sanford: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps Florida patients choose. Doctor review just $119 (medication separate).

Why Sanford Residents Choose New Hope Weight Loss

New Hope was designed around the way Sanford residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense your medication ships to your door. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.

Sanford is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

There is no New Hope Weight Loss office in Sanford, and there does not need to be, since the same doctor-led program is delivered to every corner of Florida through telehealth visits. We care for patients throughout historic downtown Sanford and the greater Seminole County area. Because everything happens by telehealth, patients across historic downtown Sanford and the greater Seminole County area get the same physician-led program without driving anywhere or sitting in a waiting room.

Distance simply stops mattering here, since every appointment for Sanford residents takes place over secure video rather than in a waiting room. We accept HSA and FSA cards for the $119 physician review, which lets many Sanford patients use pre-tax dollars toward their care. Florida is one of the most populous states in the nation, and New Hope Weight Loss serves patients across it entirely by telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Semaglutide (90-Day Metabolic Reset)

From $166/mo, or $499 for 90 days, our reset program is the route most people in Sanford choose. Semaglutide is the same active ingredient found in Wegovy and Ozempic, and branded-drug studies reported 15 to 17 percent average body-weight loss. Dr. Sharma reviews your dose monthly. Keep in mind that compounded semaglutide is not FDA-approved, is not brand-identical, and that results vary.

Tirzepatide (Dual-Action Program)

From $233/mo, tirzepatide adds a second mechanism, GIP, on top of GLP-1. In clinical trials of the branded drug, dose-qualified patients reached up to 22.5 percent loss, which is not the typical result. Tirzepatide shares its active ingredient with Mounjaro and Zepbound.

Physician review is $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Sanford

Here is how the whole thing works, start to finish, for anyone in Sanford.

First, you fill out an intake and quiz about your weight history and current health. Next, Dr. Sharma looks it over and meets you by secure video, almost always within 48 hours, to see whether compounded semaglutide or tirzepatide fits your situation. Then, if she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Sanford address in cold-pack packaging built to protect it on the road. After that, every follow-up is a video visit, so the care continues no matter where you are in .

Frequently Asked Questions, Sanford

Is there somewhere in Sanford I can visit New Hope Weight Loss?

There is no physical office in Sanford. We work from a single clinic in Costa Mesa, California, and care for Sanford, Florida patients by telehealth. Your candidacy for a compounded GLP-1 plan is confirmed when Dr. Anjmun Sharma reviews your health information during an online video appointment.

Will Sanford patients have to make any in-person trips?

No trips are necessary. We provide care to Sanford completely through telehealth, covering consults, follow-up visits, and ongoing support remotely. Once Dr. Sharma signs off, your compounded semaglutide or tirzepatide is delivered to Sanford in cold-pack shipping that preserves the correct temperature.

What does the program cost a Sanford patient?

Budget $119 for the physician visit. Semaglutide is priced from $166 monthly or $499 for 90 days, and tirzepatide from $233 monthly. The medication is a separate line item. We accept HSA, FSA, Klarna, and Affirm, and no distance surcharge is added for patients located in Sanford.

What areas of Sanford do you serve?

We serve patients from across Sanford by telehealth, including historic downtown Sanford and the greater Seminole County area.

How soon can a Sanford patient start treatment?

Most Sanford patients complete the online intake in minutes and have Dr. Sharma's video review within about 48 hours. If you are a candidate and telehealth-eligible, medication ships shortly after, so many patients begin within roughly a week of starting.

Sanford Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Sanford, Florida by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.